Synthetic Biologics (NYSE: SYN) announced that it has executed definitive purchase agreements with select institutional investors for gross proceeds of ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE